To prove whether effective delivery of endogenous antioxidants to renal tissues may ameliorate underlying pathophysiology of DN, we opted to apply CPP technologies in order to study the ameliorative effect of our Tat-fused MT and SOD proteins in OLETF rats. The gene discussed is SOD1; the disease is liver dysplastic nodule.